Development and dosimetric characterization of an in vitro benchtop Am-241 alpha irradiator platform
Listen to this summary
The authors aimed to develop and characterize a benchtop in vitro alpha irradiation platform using an Americium-241 source to facilitate preclinical studies on the radiobiology of alpha particles in cancer therapy. They successfully constructed a system that ensures dose homogeneity and stability, demonstrating feasibility for controlled alpha particle irradiation with consistent dose rates. This platform is designed to support high-throughput research and long-term investigations into the effects of alpha radiation.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from International journal of radiation oncology, biology, physics
View all →Jun 11, 2026 · International journal of radiation oncology, biology, physics
PET-Guided Modeling of Mucosal Boron Heterogeneity Improves Dose-Toxicity Prediction in BNCT
Jun 11, 2026 · International journal of radiation oncology, biology, physics
Characteristics of Crowdfunding Campaigns for Proton Therapy
More in Radiology
View all →Sep 23, 2026 · Abdominal radiology (New York)
MRI assessment of extramural venous invasion in rectal cancer: a practical pictorial review
Sep 23, 2026 · JAMA
Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · Abdominal radiology (New York)
A radiology trainee's guide to perianal fistulas
Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
